EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Ras Guanine Nucleotide-Releasing Protein-4 Inhibits Erythropoietin Production in Diabetic Mice with Kidney Disease by Degrading HIF2A

Junmei Wang, Shuai Huang, Li Zhang, Yixian He, Xian Shao, A-Shan-Jiang A-Ni-Wan, Yan Kong, Xuying Meng, Pei Yu, Saijun Zhou

Diabetes & Metabolism Journal · 2025

DOI: 10.4093/dmj.2024.0398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, 2025. Verfasst von Junmei Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tia…. Hauptthemen laut MEDLINE: Erythropoietin, Basic Helix-Loop-Helix Proteins, Diabetic Nephropathies, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, China Endocrine Metabolism Talent Research Fund, Tianjin Medical University Chu Hsien-I Memorial Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In acute and chronic renal inflammatory diseases, the activation of inflammatory cells is involved in the defect of erythropoietin (EPO) production. Ras guanine nucleotide-releasing protein-4 (RasGRP4) promotes renal inflammatory injury in type 2 diabetes mellitus (T2DM). Our study aimed to investigate the role and mechanism of RasGRP4 in the production of renal EPO in diabetes.

Methods

The degree of tissue injury was observed by pathological staining. Inflammatory cell infiltration was analyzed by immunohistochemical staining. Serum EPO levels were detected by enzyme-linked immunosorbent assay, and EPO production and renal interstitial fibrosis were analyzed by immunofluorescence. Quantitative real-time polymerase chain reaction and Western blotting were used to detect the expression of key inflammatory factors and the activation of signaling pathways. In vitro, the interaction between peripheral blood mononuclear cells (PBMCs) and C3H10T1/2 cells was investigated via cell coculture experiments.

Results

RasGRP4 decreased the expression of hypoxia-inducible factor 2-alpha (HIF2A) via the ubiquitination–proteasome degradation pathway and promoted myofibroblastic transformation by activating critical inflammatory pathways, consequently reducing the production of EPO in T2DM mice.

Conclusion

RasGRP4 participates in the production of renal EPO in diabetic mice by affecting the secretion of proinflammatory cytokines in PBMCs, degrading HIF2A, and promoting the myofibroblastic transformation of C3H10T1/2 cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErythropoietinBasic Helix-Loop-Helix ProteinsDiabetic NephropathiesDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Guanine Nucleotide Exchange FactorsAnimalsMiceMaleKidneyMice, Inbred C57BLEndothelial PAS Domain-Containing Protein 1

Stichwörter der Autor:innen

Diabetes mellitus, type 2ErythropoietinInflammationRas guanine nucleotide releasing protein 4

Substanzen

ErythropoietinBasic Helix-Loop-Helix ProteinsGuanine Nucleotide Exchange FactorsEndothelial PAS Domain-Containing Protein 1

Autor:innen und Institutionen

  • NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
  • Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, China.
  • Department of Geriatrics, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Förderung

  • National Natural Science Foundation of China
  • China Endocrine Metabolism Talent Research Fund
  • Tianjin Medical University Chu Hsien-I Memorial Hospital
  • Tianjin Key Laboratory of Metabolic Diseases
  • Bethune Charitable Foundation
  • Hubei Chen Xiaoping Science and Technology Development Fund
  • Tianjin Science and Technology Plan Project
  • Public Health Science and Technology Major Special Project

Zitieren

APA

Wang, J., Huang, S., Zhang, L., He, Y., Shao, X., A-Ni-Wan, A. S., Kong, Y., Meng, X., Yu, P., & Zhou, S. (2025). Ras Guanine Nucleotide-Releasing Protein-4 Inhibits Erythropoietin Production in Diabetic Mice with Kidney Disease by Degrading HIF2A. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2024.0398

Vancouver

Wang J, Huang S, Zhang L, He Y, Shao X, A-Ni-Wan AS, et al. Ras Guanine Nucleotide-Releasing Protein-4 Inhibits Erythropoietin Production in Diabetic Mice with Kidney Disease by Degrading HIF2A. Diabetes & Metabolism Journal. 2025. doi:10.4093/dmj.2024.0398

BibTeX
@article{Wang2025,
  author = {Wang, Junmei and Huang, Shuai and Zhang, Li and He, Yixian and Shao, Xian and A-Ni-Wan, A-Shan-Jiang and Kong, Yan and Meng, Xuying and Yu, Pei and Zhou, Saijun},
  title = {Ras Guanine Nucleotide-Releasing Protein-4 Inhibits Erythropoietin Production in Diabetic Mice with Kidney Disease by Degrading HIF2A},
  journal = {Diabetes & Metabolism Journal},
  year = {2025},
  doi = {10.4093/dmj.2024.0398}
}
Kostenlos starten →